Atlas Trials

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Clinical trial NCT07224737 · COMPLETED

Trial details

NCT number
NCT07224737
Sponsor
City of Hope Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Intrahepatic Cholangiocarcinoma (Icc)
Start date
2024-06-21
Primary completion
2026-01-18
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.